BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 29105106)

  • 1. Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.
    Busby J; McMenamin Ú; Spence A; Johnston BT; Hughes C; Cardwell CR
    Aliment Pharmacol Ther; 2018 Jan; 47(2):279-288. PubMed ID: 29105106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: A population-based cohort study.
    Doherty N; Cardwell C; Murchie P; Hill C; Azoulay L; Hicks B
    Int J Cancer; 2024 Mar; ():. PubMed ID: 38554127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral prednisolone and warfarin and risk of oesophageal cancer: A case-control study.
    Cardwell CR; McDowell RD; Hughes CM; Busby J; Murchie P
    Cancer Epidemiol; 2024 Jun; 90():102552. PubMed ID: 38447250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of initial treatment strategy and survival time on quality of end-of-life care among patients with oesophageal and gastric cancer: A population-based cohort study.
    Dalhammar K; Malmström M; Schelin M; Falkenback D; Kristensson J
    PLoS One; 2020; 15(6):e0235045. PubMed ID: 32569329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose aspirin and survival from lung cancer: a population-based cohort study.
    Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LM
    BMC Cancer; 2015 Nov; 15():911. PubMed ID: 26573580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
    Cabasag CJ; Arnold M; Piñeros M; Morgan E; Brierley J; Hofferkamp J; Kehoe S; Butler J; Bucher O; Bray F; Soerjomataram I; Parkin DM
    Int J Cancer; 2021 Sep; 149(6):1239-1246. PubMed ID: 33990959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Author response to: Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Brown LR; Crumley AB; Skipworth RJE
    Br J Surg; 2024 May; 111(5):. PubMed ID: 38814786
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Li K; Leng X; Han Y; Peng L
    Br J Surg; 2024 May; 111(5):. PubMed ID: 38814787
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
    Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
    Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study).
    Shaddy R; Canter C; Halnon N; Kochilas L; Rossano J; Bonnet D; Bush C; Zhao Z; Kantor P; Burch M; Chen F
    Am Heart J; 2017 Nov; 193():23-34. PubMed ID: 29129252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia.
    Lee HY; Kim SY; Choi KJ; Yoo BS; Cha DH; Jung HO; Ryu DR; Choi JH; Lee KJ; Park TH; Oh JH; Kim SM; Choi JY; Kim KH; Shim J; Kim WS; Choi SW; Park DG; Song PS; Hong TJ; Rhee MY; Rha SW; Park SW
    Clin Ther; 2017 Dec; 39(12):2366-2379. PubMed ID: 29150250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
    Sessa M; Mascolo A; Mortensen RN; Andersen MP; Rosano GMC; Capuano A; Rossi F; Gislason G; Enghusen-Poulsen H; Torp-Pedersen C
    Eur J Heart Fail; 2018 Mar; 20(3):548-556. PubMed ID: 29159953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Being overweight or obese as a risk factor for acute liver injury secondary to acute acetaminophen overdose.
    Chomchai S; Chomchai C
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):19-24. PubMed ID: 29148111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Helicobacter pylori infection: A clinical practice update.
    Zagari RM; Rabitti S; Eusebi LH; Bazzoli F
    Eur J Clin Invest; 2018 Jan; 48(1):. PubMed ID: 29144559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valsartan regulates TGF-β/Smads and TGF-β/p38 pathways through lncRNA CHRF to improve doxorubicin-induced heart failure.
    Chen L; Yan KP; Liu XC; Wang W; Li C; Li M; Qiu CG
    Arch Pharm Res; 2018 Jan; 41(1):101-109. PubMed ID: 29124661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial.
    Heck SL; Gulati G; Hoffmann P; von Knobelsdorff-Brenkenhoff F; Storås TH; Ree AH; Gravdehaug B; Røsjø H; Steine K; Geisler J; Schulz-Menger J; Omland T
    Eur Heart J Cardiovasc Imaging; 2018 May; 19(5):544-552. PubMed ID: 29106497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension.
    Ishak J; Rael M; Punzi H; Gradman A; Anderson LM; Patel M; Ali S; Ferguson W; Neutel J
    J Clin Hypertens (Greenwich); 2018 Jan; 20(1):143-149. PubMed ID: 29105958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension.
    Engeli S; Stinkens R; Heise T; May M; Goossens GH; Blaak EE; Havekes B; Jax T; Albrecht D; Pal P; Tegtbur U; Haufe S; Langenickel TH; Jordan J
    Hypertension; 2018 Jan; 71(1):70-77. PubMed ID: 29180454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L- and N-Type Ca Channel Blocker Cilnidipine on Changes in Heart Rate and QT Interval During Dialysis.
    Iida T; Morimoto S; Amari Y; Ando T; Ichihara A
    Kidney Blood Press Res; 2017; 42(5):933-941. PubMed ID: 29166643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin system blockers and survival in digestive system malignancies: A systematic review and meta-analysis.
    Zhou Q; Chen DS; Xin L; Zhou LQ; Zhang HT; Liu L; Yuan YW; Li SH
    Medicine (Baltimore); 2020 Feb; 99(7):e19075. PubMed ID: 32049809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.